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The induction of type I interferons (IFNs) in peripheral blood mononuclear cells (PBMCs) can be triggered by viral infection
or exposure to viral glycoproteins. Here we show that the IFN-a-inducing capacity of attenuated poliovirus vaccine strains
is dramatically enhanced in the presence of human polyvalent immunoglobulin G (IgG). The transcription of both IFN-a and
IFN-b genes was detected by RT-PCR in stimulated cells. This antibody-dependent activation of type I IFNs genes was also
observed with Formalin-inactivated or UV-inactivated poliovirus, but not with empty poliovirus capsids. The ability of
poliovirus–antibody complexes to induce IFN-a was specifically inhibited when PBMCs were preincubated with an excess of
the Fc fragment of IgG. Monoclonal antibodies directed to FcgRII (CD32) were also inhibitory, whereas antibodies to the two
other classes of Fcg receptors, CD16 and CD64, were not. Also, aggregation of FcgRII by anti-CD32 antibodies alone failed
to induce IFN-a production. Our results suggest that induction of type I interferons by poliovirus–antibody complexes
depends on CD32-mediated phagocytosis of RNA-containing viral particles. As suggested by the results of an ELISPOT
analysis, only a fraction of the IFN-a-producing cells are able to synthesize IFN-a in response to poliovirus–IgG complexes.
© 2000 Academic Press
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iINTRODUCTION
Type I interferons (IFN-a and IFN-b) are a family of
ytokines whose actions include antiviral, antiprolifera-
ive, and immunomodulatory effects. They are expressed
nd secreted as an early response to various stimuli,
ost prominently to viral infections. The double-stranded
ds) RNA viral genomes or the ds RNA produced during
irus replication appear to be important signals for IFN
ype I gene transcription (Jacobs and Langland, 1996).
owever, glutaraldehyde-fixed virus-infected cells, UV-
nactivated virus, and some viral glycoproteins by them-
elves were also previously shown to induce type I IFNs
Lebon, 1985; Ito et al., 1994; Ankel et al., 1994, 1998;
Baudoux et al., 1998). IFN-a is also produced during the
course of several pathological conditions in which no
virus appears to be involved, such as the active phase of
systemic lupus erythematosus (Vallin et al., 1999; Batteux
et al., 1999) or the Aicardi–Goutieres syndrome (Gout-
ieres et al., 1998).
Many viruses induce the production of IFN-a in cul-
ures of human peripheral blood mononuclear cells
PBMCs), among them Sendai virus and other paramyxo-
iridae, herpes simplex virus (HSV), vesicular stomatitis
1 To whom correspondence and reprint requests should be ad-
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86irus (VSV), and influenza virus (Feldman et al., 1994).
Enveloped viruses generally are better IFN-a inducers
than nonenveloped ones. However, infection of human
leukocyte cultures with poliovirus, a nonenveloped sin-
gle-stranded RNA virus, also induces IFN-a, and wild-
type poliovirus strains are better inducers than attenu-
ated strains (Pitka¨ranta et al., 1988). Different cell types
re responsible for IFN-a production, depending on the
inducing agent (for review see Fitzgerald-Bocarsly, 1993).
In PBMCs, monocytes are the predominant IFN-a-pro-
ucing cells in response to Sendai virus infection (Lebon
t al., 1982). In contrast, stimulation of PBMCs with HSV
nduces IFN-a synthesis in a subpopulation of blood
ells called “natural IFN-producing cells” (IPCs), recently
haracterized as type 2 dendritic cell precursors (Siegal
t al., 1999).
Receptors for the Fc portion of immunoglobulin G
FcgR) are involved in the clearance of immune com-
plexes, phagocytosis of antibody-coated pathogens, en-
hancement of antigen presentation, and antibody-depen-
dent cellular cytotoxicity (Wallace et al., 1994). Three
classes of such receptors, FcgRI (CD64), FcgRII (CD32),
nd FcgRIII (CD16), are expressed on human blood leu-
ocytes (Fanger et al., 1996; Wallace et al., 1994). Three
soforms of FcgRII are encoded by three separate genes:
FcgRIIA, FcgRIIB, and FcgRIIC. FcgRI binds IgG with a
sufficiently high affinity to allow occupancy by mono-
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87CD32 IN IFN-a INDUCTION BY POLIOVIRUS–IgG COMPLEXESmeric IgG. In contrast, FcgRII and FcgRIII are low-affinity
FcRs, which bind only aggregated IgG or antibodies
complexed to multivalent antigens. FcgRs can become
functionally active when they are aggregated at the cell
surface, and can internalize their ligands by endocytosis
or phagocytosis. Also, when their intracytoplasmic por-
tion displays an immunoreceptor tyrosine-based activa-
tion motif (ITAM), they trigger cell activation. In fact,
FcgRI, FcgRIIA, FcgRIIC, and FcgRIII contain ITAM,
hereas FcgRIIB does not (Dae¨ron, 1997).
In this study, we present evidence that poliovirus-
nduced production of IFN-a in PBMCs is dramatically
enhanced in the presence of polyvalent immunoglobulin
G (IgG), and that genomic single-stranded viral RNA is
required for induction. We demonstrate that antibody-
dependent IFN-a production is a consequence of the
nteraction between the Fc portion of the IgG and the
cgRII receptor (CD32). Our results suggest that it is the
genomic viral RNA that triggers IFN-a production, which
occurs after the internalization of IgG antibody-com-
plexed poliovirus particles via CD32.
RESULTS
Induction of IFN-a by poliovirus–IgG complexes
Eighteen hours after exposure of PBMCs to attenuated
poliovirus strains (Sabin), the levels of IFN-a in the cul-
ture supernatants were either very weak or below the
threshold of sensitivity of the biological IFN-a assay (#2
U/ml). The IFN-a-inducing activity was slightly stronger
ith poliovirus Sabin type 1 than with serotypes 2 and 3.
hen these poliovirus strains were incubated with a
ommercial preparation of human polyvalent IgG at con-
entrations varying from 10 to 500 mg/ml prior to addition
to PBMCs, their capacity to induce IFN-a synthesis was
ramatically enhanced (Table 1). This experiment has
een repeated many times with similar results, although
aximal IFN titer varied with different donors. Compara-
le enhancement was also obtained with the Mahoney
oliovirus type 1 strain and with coxsackievirus B2, B3,
4, and B6 (data not shown). IFN-a was absent in control
BMC cultures, either noninduced or exposed to IgG or
o a crude extract of noninfected Vero cells or both.
SV-1, a strong IFN-a inducer, was also used as a
control. In contrast to the enteroviruses employed, a
mixture of HSV-1 and polyvalent IgG resulted in less-
efficient IFN-a production than HSV-1 alone.
The antiviral activity induced by complexes of poliovi-
us with IgG was mostly the result of IFN-a, as judged by
eutralization of its biological activity with an anti-IFN-
a/b antiserum and by resistance to pH 2, and by lack of
neutralization with an anti-IFN-b specific antiserum.
The effect of IgG on the inducing ability of noninfec-
tious poliovirus was further investigated. First, PBMCs
were exposed to a Formalin-inactivated preparation of
poliovirus vaccine. As expected, no IFN-a production
t
Has observed. However, when the inactivated vaccine
as preincubated with polyvalent IgG, again the amount
f IFN-a was quite high, between 500 to 1500 IU/ml
(Table 1). The same observation was noted when UV-
inactivated poliovirus was used instead of Formalin-
treated virus. A preparation of empty poliovirus type 1
capsids devoid of RNA was also used in the induction
experiments. To keep these capsids under a native an-
tigenic form, 10 mg/ml of pirodavir was added to the
edium containing PBMCs and inducing agents. At this
oncentration, pirodavir had no inhibitory effect on IFN-a
induction, as determined with HSV-1 or attenuated-polio-
virus/antibody complexes as inducers. With or without
addition of IgG, no IFN-a induction was obtained with
empty poliovirus capsids which were used at concentra-
tions ranging from 1 ng to 1 mg/ml, respectively equiva-
lent to about 9 3 107 and 9 3 1010 viral particles/ml
Table 1).
etection of mRNA of type I interferons
The polymerase chain reaction (PCR) was used to
tudy the expression of mRNA transcripts encoding type
interferons. To detect IFN-a expression by PBMCs in
he presence of different inducers, universal IFN-a prim-
rs were used in PCR amplification. PBMCs were cul-
TABLE 1
Effects of Human Polyvalent IgG on IFN-a Induction by Attenuated
oliovirus Strains, Inactivated Poliovirus Vaccine, and Empty Poliovi-
us Capsids
Inducing agent
IFN-a titer (IU/ml)a
No IgG IgGb
None ,2—,2—,2 ,2—,2—,2
oliovirus Sabin 1c 6—3—4 600—185—1200
oliovirus Sabin 2c ,2 400
oliovirus Sabin 3c ,2—,2—,2 600—370—250
Inactivated poliovirus
formalin-treated ,2—,2—,2 1500—500—750
UV-light treatedc ,2 1600
oliovirus 1 empty
capsidsd,e ,2d—,2e ,2d—,2e
Herpes simplex virus
type 1c as control 1000—5000—300 f 300—800—6 f
Note. The human PBMC (1.5 3 106 cells) were exposed to viral
preparations either directly or after preincubation of virus with human
IgG for 45 min at 37°C. After 18 h, the supernatant was removed and
the level of IFN-a was titered by a biological assay.
a Each value represents a different cell donor. The same donors are
ompared in the absence (left) and in the presence (right) of IgG.
b Inducer and human polyvalent IgG (at a final concentration of 500
mg/ml) were preincubated for 45 min at 37°C.
c Virus-to-cell ratio: 1, except f: 0.1.
d 1 ng/ml or e1 mg/ml. Particles-to-cell ratio: d30 or e30,000.ured in medium alone or were stimulated for 6 h with
SV-1, poliovirus type 3 Sabin (without or with IgG), or
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88 PALMER ET AL.inactivated poliovirus vaccine (without or with IgG). As
the type I IFN genes do not contain introns, PCR prod-
ucts generated from DNA and RNA would be of the same
size. Thus, after DNase treatment, a no reverse transcrip-
tase control PCR was performed on every cellular RNA
extract to confirm the absence of genomic DNA. No PCR
products were detected for any of the samples in these
control reactions (data not shown). The quality of RNA
recovery and cDNA synthesis was monitored by ampli-
fication of glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) mRNA.
As shown in Fig. 1, expression of both IFN-a and IFN-b
genes was enhanced after induction of PBMCs with
poliovirus–IgG complexes. The same result was ob-
served with HSV-1 as inducer. The specificity of the
reaction was confirmed by Southern blot hybridization
with specific oligonucleotides (results not shown).
Implication of FcgRII (CD32) in the induction of IFN-a
by poliovirus–antibody complexes
We further studied the mechanism of IFN-a induction
n response to exposure of PBMCs to poliovirus–anti-
ody complexes. As summarized in Table 2, when polio-
irus attenuated strains were incubated with IgG lacking
he Fc portion of immunoglobulins such as the Fab or
(ab9)2 preparations of IgG, enhancement of IFN-a pro-
duction did not occur. However, preincubation of PBMCs
with a purified preparation of the Fc fragment of polyva-
lent IgG had an inhibitory effect on IFN-a induction by
oliovirus–antibody complexes, but had no effect when
SV-1 was used as inducer (Table 2 and Fig. 2). Like the
FIG. 1. RT-PCR amplification of IFN-A gene, IFN-B gene, and G3PDH
gene. PCR products amplified from PBMCs were separated on a 1.5%
agarose gel containing ethidium bromide. Negative and positive con-
trols contained no cDNA and genomic DNA, respectively. Controls
without RT are not shown. Unstimulated cells (lane 1), cells stimulated
with IgG alone (lane 2), poliovirus Sabin 3 strain (lane 3), poliovirus
Sabin 3-IgG complexes (lane 4), poliovirus vaccine (lane 5), poliovirus
vaccine–IgG complexes (lane 6), HSV-1 (lane 7), negative (lane 8) and
positive (lane 9) controls; lane 10: molecular weight marker (100-bp
ladder; Life Technologies, France).ative IgG, IgG fragments in the absence of poliovirus
id not induce IFN-a in PBMCs. The same results wereobserved when Formalin-inactivated polioviral vaccine
was used instead of attenuated virus.
The implication of the Fc portion of IgG led us to test
the effect of various Fcg receptor-specific monoclonal
antibodies (MAbs). PBMCs were preincubated with con-
centrations between 1 to 10 mg/ml of anti-CD16, anti-
CD32, and anti-CD64 MAb. As listed in Table 3, anti-
CD32 abolished IFN-a induction by poliovirus–antibody
omplexes, but neither anti-CD16 nor anti-CD64 was
nhibitory. Both the monoclonal anti-CD32 antibody IV.3,
hich recognizes both FcgRIIA and FcgRIIC, and AT10,
hich recognizes FcgRIIA, FcgRIIB, and FcgRIIC (Dae¨ron
t al., 1995), abolished the IFN-a production by PBMCs.
FIG. 2. Effects of the Fc fragment of IgG on IFN-a induction by
poliovirus–IgG complexes or HSV-1. PBMCs were preincubated for 45
min at 37°C with indicated amounts of the Fc fragment followed by the
addition of poliovirus–IgG complexes or HSV-1 at a cell-to-virus ratio of
1. Results are expressed as antiviral activity percentage compared to
TABLE 2
Comparison of the Effects of Human Polyvalent IgG Fragments on
IFN-a Induction by Poliovirus or HSV-1
Addition
IFN-a titer (IU/ml)
Poliovirusa HSV-1a
None ,2 1000
ative IgG (0.5 mg/ml) 750 300
Fab fragment (0.05 to 5 mg/ml) ,2 ND
F(ab’)2 fragment
b ,2 500
c fragment (1 mg/ml) ,2 1000
ative IgG and Fc fragment ,2 ND
Note. In these experiments, viruses (HSV-1 or poliovirus) were pre-
incubated with native polyvalent IgG or with their Fab or F(ab’)2 frag-
ents. The preparation of the Fc fragment was added to PBMC sus-
ension 45 min before induction by HSV-1 or poliovirus—IgG preincu-
ated mixture. ND, not done.
a Virus-to-cell ratio: 1.
b The preparation of the F(ab’)2 fragment was tested at a dilution
containing the same neutralizing activity on poliovirus type 1 as 0.5
mg/ml of native IgG.induction without Fc fragments. Control titers of IFN-a were 750 IU/ml
(poliovirus–IgG) and 1000 IU/ml (HSV-1).
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89CD32 IN IFN-a INDUCTION BY POLIOVIRUS–IgG COMPLEXESF(ab9)2 fragments of the same two MAbs also decreased
he IFN-a induction, although IV.3 F(ab9)2 fragments were
ess inhibitory than AT10 F(ab9)2 fragments, as shown in
Fig. 3. These monoclonal antibodies had no effect on the
induction of IFN-a by HSV-1 used as control with the
same PBMCs. A monoclonal antibody (MAb Gal-Cer),
which recognized galactosyl cerebrosides and had pre-
viously been shown to inhibit IFN-a induction by HSV-1
(Ankel et al., 1998), had no effect on IFN-a production in
response to poliovirus–IgG stimulation (Table 3).
To elucidate whether IFN-a induction by the poliovi-
rus–IgG complex is the result of aggregation of FcgRII
receptors on the cell surface, we triggered cell activation
by immunological aggregation of FcgRII by crosslinking
ith anti-CD32 MAb IV.3 and F(ab9)2 anti-mouse Ig. Al-
hough the efficiency of CD32 aggregation was con-
irmed by the presence of TNF-a in the supernatant
(Debets et al., 1988), no IFN-a activity was detectable.
hus, aggregation of FcgRII alone was not sufficient for
FN-a induction, suggesting that CD32-mediated inter-
alization of the entire poliovirus–IgG complex has to
ccur to trigger the inducing event.
requency of IFN-a-producing cells in response to
poliovirus–IgG and HSV-1 stimulation
Previous data have shown that natural IFN-a-produc-
ing cells (IPCs) are nonadherent, low-density mononu-
clear cells (Fitzgerald-Bocarsly, 1993). To compare the
frequency of IPC in PBMCs that produce IFN-a in re-
ponse to poliovirus–IgG to that of the IPC responding to
SV-1, the following analysis was carried out. The non-
dherent, low-density cell population was therefore en-
iched on a 16% metrizamide cushion. Cells were sepa-
TABLE 3
Effects of MAbs Specific for Fcg Receptors or Galactosyl
Cerebroside on IFN-a Induction by Poliovirus-IgG or HSV-1
Inducing agent
% inhibition of IFN-a induction
after preincubation of PBMC
with MAbs toa
CD16 CD32b CD64 Gal-Cer
Poliovirus Sabin 3 plus IgG 0 100 0 0
Poliovirus vaccine plus IgG 0 100 0 ND
HSV-1 0 0 0 80
Note. Results represent three independent experiments. Other con-
ditions are as in Table 2. Control experiments showed that PBMC
exposed to anti-Fcg receptors or anti-Gal-Cer MAbs alone did not
produce IFN-a. ND, not done.
a PBMC were preincubated with Fcg receptors MAbs at 2 mg/ml for
5 min at 37°C. Anti-Gal-Cer MAb was present at 1 mg/ml.
b Anti-CD32 IV.3 and AT10 MAbs were separately used with the same
results.ated in two fractions : the cell population of low density
#16% metrizamide) was enriched in IPCs, whereas no
a
oPCs and only a weak IFN activity could be detected in
he pellet (Table 4). The amounts of IFN-a produced after
induction was positively correlated to the number of
IPCs. Although the frequency of IPCs was always low
(,1%), there were more IPCs in response to HSV stim-
ulation (18 and 400 per 105 cells, respectively) than in
esponse to poliovirus–IgG (3 and 10 per 105 cells, re-
spectively). The estimated yield of IFN-a per IPC was
around 100 IU for poliovirus–IgG and for HSV in Experi-
ment 1, but only 13 for HSV in Experiment 2. These two
experiments were performed with different cell donors.
DISCUSSION
In this study, we investigated the production of IFN-a
by human PBMCs exposed to different preparations of
polioviral particles. In our experimental conditions, the
Sabin attenuated vaccine strains induced less IFN-a
than previously reported (Pitka¨ranta, 1991). This discrep-
ancy is probably the result of our collecting the super-
natants for IFN-a titration 18 h rather than 2 or 6 days
fter induction. Our present work is the first description
f an enhancement of IFN-a production by preincubating
iruses with polyvalent human IgG. This effect was very
eproducible, although the amounts of IFN-a varied
idely between different cell donors. The antiviral activity
ssay was performed on MDBK cells, which do not
espond to human IFN-g and respond poorly to human
FN-b (Gresser, 1974). This antiviral activity was further
characterized as mainly IFN-a by immunoneutralization
ests with specific antisera. The detection of interferons
ype I mRNA by RT-PCR confirmed the activation of the
FN A gene transcription 6 h after induction. However, an
nhancement of the transcriptional activity of IFN B gene
as also observed.
FIG. 3. Effects of anti-CD32 MAbs on IFN-a induction by poliovirus–
gG complexes. PBMCs were preincubated for 45 min at 37°C with
ndicated amounts of native anti-CD32 Mab IV.3 or AT10 (dashed line)
r with F(ab9)2 fragments MAb IV.3 or AT10. After addition of poliovirus–
gG complexes and further incubation for 18 h, titers of IFN-a were
etermined in the supernatant. Results are expressed as antiviral
ctivity percentage compared to induction without MAbs. Control titers
f IFN-a were 750 IU/ml (poliovirus–IgG).
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90 PALMER ET AL.Thus, we report a mechanism of IFN type I induction in
human PBMCs not previously described. The experi-
ments performed with preparations of IgG fragments and
with antibodies directed to Fc receptors showed that the
IFN-a production observed after stimulation of PBMCs
with poliovirus–IgG complexes resulted from an interac-
tion between the Fc portion of the IgG and FcgRII (CD32).
Indeed, the synthesis of IFN-a after this stimulation was
strongly increased only in the presence of intact IgG but
not in the presence of Fab or F(ab9)2 fragments. More-
over, preincubation of PBMCs with an excess of Fc
fragments inhibited the IFN-a production induced by
poliovirus–IgG complex, most probably through compe-
tition with the Fc portion of the intact molecules. When
various antibodies which block the binding of Ig to FcR
were employed, IFN-a production was inhibited only by
nti-FcgRII (CD32), and not by anti-FcgRI (CD64) or anti-
cgRIII (CD16), suggesting that the later FcRs are either
not involved in IFN-a induction by viral–antibody com-
plexes or not expressed on the IFN-a-producing cells.
Fanger et al. (1996) previously showed that freshly iso-
lated monocytes and blood dendritic cells express CD32
and CD64, but not CD16. In another study, both CD16 and
CD64 were found to be absent on natural interferon-
producing cells (Svensson et al., 1996).
FcgRII are low-affinity Fc receptors that bind only ag-
gregated IgG or IgG complexed to multivalent antigens.
Such binding results in FcR aggregation, which, depend-
ing on the FcgR subtype, can induce cell activation,
endocytosis, and/or phagocytosis. Three isoforms of
FcgRII are described: FcgRIIB mediates endocytosis,
hereas FcgRIIA and FcgRIIC trigger both endocytosis
nd cell activation. The inhibition experiments with
ouse anti-CD32 Mabs IV.3 or AT10 showed a total
brogation of IFN-a production. To avoid interference
etween the Fc portion of murine MAb and the human Fc
eceptor, purified IgG antibodies from the two anti-CD32
T
Frequency of IFN-a Producing Cells (IPCs) and IFN
or HSV-1 in PBM
Experiment Inducerb IPCc
1 Poliovirus–IgG 3
HSV-1 18
2 Poliovirus–IgG 10
HSV 400
a Nonadherent PBMC were separated by centrifugation in 16% metr
b Experimental conditions was as in Table 2.
c ELISPOT positive cells/105 cells. ELISPOT assays were as describAb clones were treated with pepsin. The fragment IV.3
(ab9)2, which recognizes only FcgRIIA and FcgRIIC, par-
r
stially inhibited IFN-a induction by poliovirus–IgG com-
lexes (Fig. 3). On the other hand, AT10 F(ab9)2 fragment,
hich recognizes the three isoforms of FcgR, completely
inhibited IFN-a induction. Since the three isoforms of
FcgR can mediate endocytosis, our results suggest that
IFN-a-inducing activity is related to internalization of po-
iovirus–IgG complexes. The ability to trigger signal
ransduction and cell activation through immunological
rosslinking of MAb directed to ITAM-bearing FcR has
een demonstrated in different experimental conditions
Dae¨ron, 1997). However, since immunological aggrega-
ion of FcgRII by anti-CD32 Mab and F(ab9)2 anti-mouse
Ig did not lead to IFN-a synthesis by PBMCs, the FcgRII-
mediated IFN-a production does not seem to be a result
f cell activation alone.
The antibody-dependent enhancement of IFN-a induc-
ion also occurred with Formalin- or UV-inactivated viral
articles, but not with empty N-antigenic poliovirus cap-
ids, even when used at a capsid-to-cell ratio of up to
04/cell. Thus, enhancement of IFN-a induction by polio-
virus–antibody complexes is dependent on the RNA con-
tent of the viral particles, although it is independent of
their infectivity. Indeed, no significant elevation of polio-
virus titers was observed in the supernatant of PBMCs
exposed to poliovirus Sabin strains. Previous studies
showed that attenuated Sabin polioviral strains types 2
and 3 do not replicate in these cells, although the Sabin
type 1 strain replicates slower and to lower titers than
the virulent counterpart, poliovirus 1 Mahoney (Freistadt
et al., 1996). We note that poliovirus type 1 is the only
Sabin strain that can induce little amounts of IFN-a
without the addition of IgG in our experimental condi-
tions (Table 1).
Taken together, our results suggest that IFN-a induc-
ion depends not only on internalization of the virus–IgG
omplex but furthermore on the release of viral RNA
nside the cells. After binding to cell surface poliovirus
duction in Response to Induction by Poliovirus-IgG
ifferent Density
Cell densitya
6% .16%
IFN-a (IU/ml) IPCc IFN-a (IU/ml)
250 ,1 ,3
2000 ,1 ,3
1200 ,1 20
5200 ,1 200
as described under Materials and Methods.
er Materials and Methods according to Cederblad and Alm (1990).ABLE 4
-a Pro
Cs of D
#1
izamideeceptor, the N terminus of VP1, which is on the interior
ide of the native particle, is exposed on the surface of
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91CD32 IN IFN-a INDUCTION BY POLIOVIRUS–IgG COMPLEXESthe virus. The formation of such altered particles, some-
times called A particles, is an essential step in the cell
entry of poliovirus. On the other hand, attachment of
antibody-complexed poliovirus to cells via the Fc recep-
tor, which does not lead to the production of conforma-
tionaly changed particles, fails to lead to productive in-
fection. In contrast foot-and-mouth disease virus, another
member of the Picornaviridae family, can infect nonsus-
ceptible cells in an antibody-dependent manner via Fc
receptors (Mason et al., 1993). Thus, interaction of polio-
virus with its cell receptor is required to change the
capsid conformation and allow the uncoating process
and viral replication (Arita et al., 1999). Such a conforma-
tional change does not occur with Formalin-fixed polio-
virus, thus IFN-a induction obtained with poliovirus–an-
tibody complexes does not undergo classical uncoating
of viral capsid. Possibly, the polioviral particles are inter-
nalized via the FcR by phagocytosis, and degradation of
the viral components by cellular hydrolytic enzymes
could then trigger IFN-a production by the release of
viral single-stranded RNA, alone or complexed to viral
proteins, into the cytoplasm. In the cell, the single-
stranded genomic polioviral RNA could act as a partially
double-stranded RNA since the nontranslated regions of
its genome present secondary structures (Wimmer et al.,
1993).
In similar studies, FcgRII-dependent production of
FN-a was also observed, when PBMCs were exposed to
ntibody complexed to other viruses such as coxsack-
evirus B, rotavirus, or adenovirus (P. Lebon and J. Cohen,
npublished observations). We also found that IFN-a
production in PBMCs stimulated with serum samples
from patients with systemic lupus erythematosus was
likewise mediated by FcgRII (Batteux et al., 1999). How-
ever, the mechanism of antibody-stimulated IFN-a induc-
ion is not involved for every virus. Polyvalent IgG did not
nhance, but rather inhibited, the IFN-a-inducing capac-
ity of HSV-1 (Tables 1 and 2). Other studies have shown
that specific antibodies directed to interferogenic viral
glycoproteins blocked IFN-a induction (Charley and
Laude, 1988; Capobianchi et al., 1992; Ankel et al., 1998).
We observed several other differences between HSV-1-
and poliovirus/IgG-dependent IFN-a induction. First, the
inhibitory effect of anti-CD32 MAb on IFN-a production
as not observed when HSV was used as an inducer.
econd, MAb directed to galactosyl cerebroside inhib-
ted IFN-a induction by HIV and HSV-1 (Ankel et al., 1996,
1998), but not poliovirus–IgG induction. Third, the cells
producing IFN-a in the presence of HSV-1 were more
frequent than those able to synthesize IFN-a in response
to poliovirus–IgG. The fact that poliovirus/IgG-induced
IPCs copurified on metrizamide gradients with HSV-in-
duced IPCs suggests that only a subpopulation of the
natural IFN-a-producing cells was induced by polio-
virus–antibody complexes. Until now, the low number of
natural IFN-a-producing cells in peripheral blood and thefailure to recognize unique cell surface determinants for
these cells have made purification of the natural IPC
difficult. Recent advances in the characterization and
isolation of this population will allow the study of the
effects of inducing agents on purified NIPC (Siegal et al.,
1999; Cella et al., 1999).
The initial mechanism responsible for type I IFN in-
duction could be posttranslational modifications of IFN
regulatory factors (IRFs). Our data support the view that
the cell–virus interactions might lead to activation of IRFs
by different ways. Both enveloped viruses (acting by
some of their glycoproteins) and nonenveloped ones
(acting via their genetic material) could induce type I IFN
through independent mechanisms which do not require
viral replication. The cellular process leading to activa-
tion of IRFs is still not well understood, so it is important
to describe and investigate every inducing condition.
Human enterovirus infections are often associated with
high levels of IFN-a in blood or cerebrospinal fluid sam-
ples (Tardieu et al., 1986). Since these viruses by them-
selves are poor inducers in vitro, it is possible that their
complexation to specific antibodies explains the ele-
vated IFN-a titers that are seen in such patients.
MATERIALS AND METHODS
Cells and virus
Peripheral blood mononuclear cells (PBMCs) from
healthy donors negative for hepatitis B and C, HIV, and
HTLV-1 markers were prepared from fresh buffy coats
containing citrate as anticoagulant. They were provided
by the Etablissement de Transfusion Sanguine (Paris,
France). PBMCs were separated by density gradient
centrifugation on Ficoll–Hypaque (Pharmacia, France),
washed twice in RPMI 1640 medium (Life-Technologies,
France) with penicillin (250 IU/ml) and gentamicin (80
mg/ml), and used in induction experiments on the same
day.
The attenuated poliovirus Sabin strains were propa-
gated at a low multiplicity in African green monkey kid-
ney cells (Vero). Between 48 and 72 h postinfection,
when the cytopathic effect exceeded 75%, cultures were
frozen and thawed twice before centrifugation (10 min,
2000 rpm, 4°C). Supernatants were collected and stored
in small aliquots at 280°C. Virus TCID50 titers were
measured by end-point dilution. The same procedures
were followed for coxsackievirus B preparations. Stocks
of clinical isolate of herpes simplex virus type 1 (HSV-1)
were prepared from supernatants of infected Vero cells
and had a titer of 2 3 107 plaque-forming units (pfu) per
ml. Formalin-inactivated poliovirus vaccine was obtained
from Pasteur Merieux MSD (Lyon, France). It was a
mixture of the three serotypes of poliovirus. An aliquot of
poliovirus type 3 was exposed to a UV-light source (15 W;
5-cm distance from the virus suspension) for 1 min,
resulting in a decrease of more than 5 log to the infec-
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92 PALMER ET AL.tivity titers of the virus. The empty capsids were prepared
from poliovirus type 1, strain Mahoney. They were puri-
fied (.99%) by sucrose gradient ultracentrifugation un-
der a native antigenic form (identical to that of virions) in
the presence of pirodavir (R 77975, a gift from Janssen
Research Foundation). Pirodavir is a capsid-binding
compound, which neutralizes infectivity of viral particles
by capsid stabilization. In all experiments with the empty
capsids, pirodavir was present at a concentration of 10
mg/ml. Antigenicity of these capsids was checked with a
set of monoclonal antibodies in a protein A-aided immu-
noprecipitation using microtitration plates (Vrijsen et al.,
1983). The monoclonal antibodies used were directed
against the four neutralizing sites of poliovirus type 1
(antibody 95, site 1; antibody 36-5h2, site 2; antibody 424,
site 3A; antibody 35-2b6, site 3B). A nonneutralizing an-
tibody 39-5b4 was also used; this antibody recognizes H
antigen (i.e., virions heated for 20 min at 56°C) but does
not recognize either virions or procapsids (Rombaut et
al., 1990). It was found that the capsids were exclusively
N-antigenic.
Immunological reagents
Human polyvalent IgG (TEGELINE) was prepared by
the Laboratoire Franc¸ais du Fractionnement et des Bio-
technologies (Les Ulis, France). This preparation was
composed of 97.6 6 0.4% of intact IgG. F(ab9)2 fragments
of human polyvalent IgG were prepared by pepsin diges-
tion and purified with a Protein G–Sepharose column
(Pharmacia, France) according to the procedure supplied
by the manufacturer. The neutralizing activity of native
immunoglobulins or F(ab9)2 fragments was tested
against poliovirus Sabin 1 strain with standard proce-
dures. Although the IgG preparation used in these ex-
periments contained a high titer of neutralizing antibod-
ies against poliovirus (1/640), the poliovirus strains were
not totally neutralized in the experimental conditions
described above. Native or fragmented immunoglobulins
were used at dilutions giving the same neutralizing titers.
Human polyclonal Fab and purified Fcg fragments
were a gift from M. F. Makula (Pasteur-Merieux-Con-
naugh, Lyon, France). The effect of antibodies directed
against Fc receptors was tested with affinity chromatog-
raphy-purified monoclonal antibodies (MAbs) anti-CD16
(clone 3G8; Immunotech, Marseille, France), anti-CD64
(clone 10.1; Cymbus Biotechnology, Hants, UK), and anti-
CD32: clone IV.3 (Looney, 1986) and clone AT10 (Green-
man, 1991). The F(ab9)2 fragments of anti-CD32 MAbs
(clones IV.3 and AT10) were prepared as previously de-
scribed (Dae¨ron et al., 1995). Anti-galactosyl-cerebroside
(Gal-Cer) MAb was obtained from Boehringer-Mannheim
(Mannheim, Germany). Anti-IFN-a/b neutralizing sheep
olyclonal antibody was prepared at Unite´ 43 INSERM
Paris, France). Anti-IFN-b was kindly provided by M.
Tovey (CNRS, Villejuif, France). A goat F(ab9)2 anti-mouse
D
wIg was obtained from Jackson Immunoresearch Labora-
tories (Immunotech).
IFN-a induction of PBMCs and inhibition experiments
Freshly isolated PBMCs (1.5 3 106 cells) were incu-
bated at 37°C for 16–18 h in 0.5 ml RPMI supplemented
with 10% heat-inactivated fetal calf serum (FCS), with or
without inducing preparations containing various con-
centrations of antibodies and viral particles (as indi-
cated). Samples of virus preparations were added into
PBMC cultures at a final multiplicity of infection of 1
TCID50/cell.
The experiments of IFN-a induction in PBMCs were
repeated after preincubation of the cells for 45 min at
37°C with 1 to 10 mg/ml of anti-CD16, anti-CD32 (clone
V.3 or AT10), anti-CD64 MAbs, 0.5 to 2 mg/ml of anti-GalC
MAb, and 0.5 to 1.6 mg/ml of Fc fragment of polyvalent
immunoglobulins.
IFN-a and TNF-a assay
At the end of the inducing reaction, 18 h after addition
f the inducer, supernatants were collected for IFN-a
assay. A 5% aliquot of 1 N HCl was added to inactivate
HSV. This procedure was not necessary with poliovirus
since it cannot infect bovine cells. The supernatants
were serially diluted twofold in a 96-microwell plate and
MDBK (Madin–Darby bovine kidney) cells in MEM/10%
FCS were added. After incubation for 18 h at 37°C, the
cells were infected with VSV. Cytopathic effects were
scored under the microscope 18 h later. Titration end
points represent dilutions which gave destruction of 50%
of the cells. A laboratory reference of human IFN-a,
hich had been standardized with the NIH Ga 023-902-
30 reference, was included with each titration. Inter-
eron titers are expressed as international units (IU)/ml.
ne international unit of IFN activity (IU) represents the
eciprocal of the dilution that results in 50% of cell de-
truction, corrected for the value obtained with the IFN-a
standard.
Quantitative determination of tumor necrosis factor
(TNF-a) in cell culture medium was performed by an
immunoenzymatic assay (TNF-a ELISA Kit; Biotest, Buc,
France). The minimum detectable dose of TNF-a was 10
g/ml.
ype I interferon mRNA detection by RT-PCR
Six hours after the addition of the inducing agent, RNA
as extracted from PBMCs (1.5 3 106 cells) with a
uanidinium isothiocyanate-phenol solution. After iso-
ropanol precipitation, the pellet was treated with
Nase-free DNase I (Roche Diagnostics, France) for 30
in at 37°C. To eliminate DNase, a second extraction
as performed. The absence of contaminating genomic
NA was verified for each extract by lack of amplification
ithout reverse transcriptase. The RNA extract was
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tion with random hexamers as primers.
One consensus oligonucleotide primer pair was de-
signed to amplify all the subspecies of IFN-a genes,
leading to the synthesis of a 375-bp amplicon. The se-
quences of oligonucleotides were as follows: sense
primer (59-TTCCTCCTGYYTGAWGGACAGA-39) (Y 5 C or
T, W 5 A or T), antisense primer (59-GATCTCATGATTTCT-
GCTCTGACA-39). The second primer pair was chosen to
create a 470-bp PCR product from the IFN-b gene (Lal-
emand et al., 1996). A portion of 165 bp of the glyceral-
ehyde-3-phosphate dehydrogenase (G3PDH) gene,
hich is expressed constitutively in all tissues, was
mplified to verify adequate nucleic acid extraction,
Nase treatment, reverse transcription, and amplifica-
ion (sense: 59-CTCTGGTAAAGTGGATATTGTT-39; anti-
ense: 59-TCCTGGAAGATGGTGATGG-39).
An aliquot of the cDNA corresponding approximately
o the extract of 50,000 cells was amplified. PCR reac-
ions were carried out in a total volume of 50 ml contain-
ing 10 mM Tris–HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2,
100 mM deoxyribonucleosides, primers (IFN-a: antisense
primer, 0.2 mM, sense primer, 1 mM; IFN-b: 0.5 mM of
ach primer; G3PDH: 0.2 mM of each primer) and 1.7 U of
Thermus aquaticus DNA polymerase (Boehringer-Mann-
heim, France). Glycerol (5%) was added to the mixture for
IFN-a PCR. After an initial denaturing step at 94°C for 3
min, the mixture was amplified in a Perkin–Elmer 9600
thermocycler by one set of 35 successive cycles of heat-
ing at 94°C for 15 s, annealing at 58°C for IFN-a and
G3PDH and 53°C for IFN-b for 15 s, followed by an
extension at 72°C for 25 s. A final 72°C step for 5 min
was done to allow complete extension of PCR products.
The specific DNA band was detected by ethidium bro-
mide staining after electrophoresis through a 1.5% aga-
rose gel (Seakem; FMC BioProducts, TEBU, France),
followed by DNA blotting and hybridization with digoxi-
genin-labeled oligonucleotide probes (IFN-a: 59-TC-
CATGAGATGATCCAGCAGA-39; IFN-b: 59-AAGCTCCT-
GTGGCAATTGAAT-39). The procedure was done according
to the manufacturer’s instructions (Boehringer-Mannheim).
ELISPOT assay
The ELISPOT (solid-phase enzyme-linked immuno-
spot) assay for the determination of frequency of IPCs
was performed as previously described (Cederblad and
Alm, 1990). The cell population used for the ELISPOT
assay was enriched in IPCs following centrifugation of
nonadherent PBMCs on a cushion of 16% metrizamide
(Sigma, France), as described previously (Nowacki and
Charley, 1993). Briefly, cells from the interface and from
the pellet were collected, washed twice, and used for
induction. After 18 h at 37°C, the induced cells were
transferred to nitrocellulose microplates coated with
AS94 anti-IFN-a antibody and incubated overnight. IPCs
Fere revealed by the successive addition of LT27: 293
nd 297 anti-IFN-a MAbs, peroxidase-labeled anti-
ouse antibody, and substrate. [AS94, LT27: 293 and 297
nti-IFN-a MAbs were kindly provided by B. Cederblad
BMC, Uppsala, Sweden).] Spots were counted and the
requency of IPCs was calculated from the total number
f cells present in each well.
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